Robert C. Fletcher, Senior VP, Business Development & Strategy at IDERA PHARMACEUTICALS, INC. (IDRA), sold 1,615 shares at $1.78 ($3K) on 2020-01-07, disclosed to the SEC on 2020-01-14.
Scheduled sale ($3k) by Senior VP, Business Development & Strategy under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.